Noseworthy John H 4

What Happened
John H. Noseworthy, a director of UnitedHealth Group (UNH), was granted 320 deferred stock units on 2026-04-01 as regular quarterly director compensation. The award shows an acquisition price of $0.00 (total reported value $0). According to the filing, the units are immediately vested but must be retained until he leaves the Board.

Key Details

• Transaction date: 2026-04-01; Filing date: 2026-04-06 (appears later than the standard 2-business-day Form 4 deadline).
• Transaction type/code: Award/Grant (A).
• Amount: 320 deferred stock units; price reported $0.00; total value $0 (per Form 4 reporting).
• Vesting/holding: Units are immediately vested but must be held until completion of Board service (per footnote).
• Shares owned after transaction: Not reported on the provided Form 4 data.
• No sale, purchase, option exercise, tax withholding, or 10b5-1 plan noted.

Context
Deferred stock unit grants to non-employee directors are routine compensation and do not necessarily signal a buy/sell opinion by the director. Because the units must be retained until departure from the Board, they are not immediately marketable. The late filing (if confirmed) is an administrative matter and does not change the nature of the compensation reported.